Back
Sangamo Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison
Sell
49
SGMO
Sangamo Therapeutics
Last Price:
1.95
Seasonality Move:
29.11%
Sell
30
CATX
Perspective Therapeutics
Last Price:
2.99
Seasonality Move:
34.33%
Sell
49
Sangamo Therapeutics (SGMO)
is a Sell
Is Sangamo Therapeutics a Buy, Sell or Hold?
- The current Sangamo Therapeutics [SGMO] share price is $1.96. The Score for SGMO is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- SGMO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SGMO Stock Price Chart
What is Sangamo Therapeutics's stock price today?
-
The Sangamo Therapeutics share price today is $1.96
The current trend is moderately bearish and SGMO is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
SGMO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 51.9 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.44 - 2.48) | Sell |
Bollinger Bands (100): | (0.45 - 1.67) | Buy |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.83 | Sell |
Relative Strength Index (14 RSI): | 9.64 | Sell |
Chaikin Money Flow: | -11653674 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.08 - 12.98) | Sell |
Bollinger Bands (100): | (10.5 - 14.68) | Sell |
SGMO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.14 | Sell |
20-day SMA: | 2.15 | Sell |
50-day SMA: | 1.41 | Buy |
200-day SMA: | 0.86 | Buy |
8-day EMA: | 2.08 | Sell |
20-day EMA: | 2.01 | Sell |
50-day EMA: | 1.59 | Buy |
200-day EMA: | 1.05 | Buy |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.54 | Sell |
20-day SMA: | 10.1 | Sell |
50-day SMA: | 11.82 | Sell |
200-day SMA: | 12.75 | Sell |
8-day EMA: | 7.04 | Sell |
20-day EMA: | 9.29 | Sell |
50-day EMA: | 11.19 | Sell |
200-day EMA: | 11.43 | Sell |
Sangamo Therapeutics Earnings Growth & SGMO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.32 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.
Sangamo Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |